News
ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study - Yahoo Finance
FREMONT, CA, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback